iRhythm Holdings Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
2,400
- Stock Symbol
-
IRTC
- Investments
-
3
- Share Price
-
$93.57
- (As of Thursday Closing)
iRhythm Holdings General Information
Description
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Contact Information
Website
www.irhythmtech.comCorporate Office
- 699 8th Street
- Suite 600
- San Francisco, CA 94103
- United States
Corporate Office
- 699 8th Street
- Suite 600
- San Francisco, CA 94103
- United States
iRhythm Holdings Stock Performance
As of 12-Nov-2026, iRhythm Holdings’s stock price is $93.57. Its current market cap is $3.1B with 33.2M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $93.57 | $88.68 | $82.85 - $192.47 | $3.1B | 33.2M | 659K | -$1.18 |
iRhythm Holdings Financials Summary
As of 30-Sep-2026, iRhythm Holdings has a trailing 12-month revenue of $854M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,927,650 | 5,884,763 | 3,035,475 | 3,254,119 |
| Revenue | 854,044 | 747,138 | 591,839 | 492,681 |
| EBITDA | (17,218) | (25,486) | (96,064) | (103,215) |
| Net Income | (38,586) | (44,551) | (113,289) | (123,406) |
| Total Assets | 1,091,441 | 1,020,042 | 931,449 | 433,144 |
| Total Debt | 770,734 | 731,184 | 736,909 | 129,824 |
iRhythm Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
iRhythm Holdings Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
iRhythm Holdings Comparisons
Industry
Financing
Details
iRhythm Holdings Competitors (16)
One of iRhythm Holdings’s 16 competitors is InfoBionic.Ai, a Venture Capital-Backed company based in Chelmsford, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| InfoBionic.Ai | Venture Capital-Backed | Chelmsford, MA | ||||
| Philips | Corporation | Amsterdam, Netherlands | ||||
| CVRx | Formerly VC-backed | Minneapolis, MN | ||||
| Spacelabs Healthcare | Corporate Backed or Acquired | Snoqualmie, WA | ||||
| Norm. | Venture Capital-Backed | Dublin, Ireland |
iRhythm Holdings Patents
iRhythm Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260294343-A1 | Viscoelastic foam sensor mount | Pending | 31-Mar-2025 | ||
| WO-2026212874-A1 | Viscoelastic foam sensor mount | Pending | 31-Mar-2025 | ||
| US-20260232205-A1 | Physiological signal detection and correlation | Pending | 07-Feb-2025 | ||
| WO-2026169522-A1 | Physiological signal detection and correlation | Pending | 07-Feb-2025 | ||
| US-20260182847-A1 | Multi-sensor differential measurement for blood pressure determination | Pending | 30-Dec-2024 | A61B5/02125 |
iRhythm Holdings Signals
iRhythm Holdings Investments & Acquisitions (3)
iRhythm Holdings’s most recent deal was a Merger/Acquisition with VitalConnect for . The deal was made on 05-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| VitalConnect | 05-Oct-2026 | Merger/Acquisition | Monitoring Equipment | ||
| Lucem Health | 30-Mar-2026 | Later Stage VC | Decision/Risk Analysis | ||
| Heartbeat Health | 09-Jul-2024 | Later Stage VC | Clinics/Outpatient Services |
iRhythm Holdings ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
24.06 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
iRhythm Holdings Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| VitalConnect | San Jose, CA | 2011 |
iRhythm Holdings FAQs
-
When was iRhythm Holdings founded?
iRhythm Holdings was founded in 2006.
-
Where is iRhythm Holdings headquartered?
iRhythm Holdings is headquartered in San Francisco, CA.
-
What is the size of iRhythm Holdings?
iRhythm Holdings has 2,400 total employees.
-
What industry is iRhythm Holdings in?
iRhythm Holdings’s primary industry is Monitoring Equipment.
-
Is iRhythm Holdings a private or public company?
iRhythm Holdings is a Public company.
-
What is iRhythm Holdings’s stock symbol?
The ticker symbol for iRhythm Holdings is IRTC.
-
What is the current stock price of iRhythm Holdings?
As of 12-Nov-2026 the stock price of iRhythm Holdings is $93.57.
-
What is the current market cap of iRhythm Holdings?
The current market capitalization of iRhythm Holdings is $3.1B.
-
What is iRhythm Holdings’s current revenue?
The trailing twelve month revenue for iRhythm Holdings is $854M.
-
Who are iRhythm Holdings’s competitors?
InfoBionic.Ai, Philips, CVRx, Spacelabs Healthcare, and Norm. are some of the 16 competitors of iRhythm Holdings.
-
What is iRhythm Holdings’s annual earnings per share (EPS)?
iRhythm Holdings’s EPS for 12 months was -$1.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process